Hexarelin peptide OXY-HEXA (5 mg) OxyPharma

Catalogue entry: Hexarelin peptide OXY-HEXA (5 mg) OxyPharma. Labelled content: 5 mg. Listed pack: 1 vial. The amount identifies labelled product content, not an administration dose.

Identity and mechanism

Hexarelin is a synthetic hexapeptide growth-hormone secretagogue. It stimulates pathways associated with the ghrelin receptor, rather than acting as a direct replacement for GH. Comparisons with GHRP-2 and GHRP-6 help describe a research family, while differences in hormonal responses remain important.

What the research measured

Imbimbo and colleagues reported human pharmacological research in the European Journal of Clinical Pharmacology in 1994. Arvat and colleagues later compared endocrine responses to Hexarelin and GHRP-2, including hormones beyond GH. These studies address physiological signalling and do not establish useful muscle growth, injury recovery or long-term performance benefits in athletes.

Sporting claims and limitations

The impression that a larger GH response must be better overlooks selectivity and downstream effects. Cortisol, prolactin and other endocrine responses are relevant to interpreting this compound's experiments. Metabolic consequences and individual endocrine conditions cannot be inferred from a simple product label. Research claims about Ipamorelin do not establish the same selectivity or tolerability for Hexarelin.

Product identity and documentation

The selected option records labelled content and presentation, not an evidence-based sporting regimen. To assess this item, require identification of Hexarelin, a traceable lot and analytical methods appropriate to the actual material. Similar vial appearance or a generic peptide purity claim cannot establish equivalence to the substance studied in a clinical experiment. Composition and batch quality remain product-specific questions.